Similar risk of exercise‐related hypoglycaemia for insulin degludec to that for insulin glargine in patients with type 1 diabetes: a randomized cross‐over trial
Author:
Affiliation:
1. Profil Neuss Germany
2. Diabetes and Endocrinology Department Swansea University Swansea UK
3. Novo Nordisk A/S Søborg Denmark
4. Novo Nordisk Inc. Plainsboro NJ USA
Funder
Biocon
Boehringer Ingelheim
Eli Lilly and Company
Medtronic
Novo Nordisk
Novartis
Sanofi
British Microcirculation Society
GlaxoSmithKline
Johnson and Johnson
Pfizer
Roche
Sanofi-Aventis Korea Company
Schering-Plough
Takeda Pharmaceuticals U.S.A.
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12588
Reference15 articles.
1. Blood glucose responses to reductions in pre-exercise rapid-acting insulin for 24 h after running in individuals with type 1 diabetes
2. Effects of Moderate-to-Vigorous Intensity Physical Activity on Overnight and Next-Day Hypoglycemia in Active Adolescents With Type 1 Diabetes
3. Type 1 Diabetes and Vigorous Exercise: Applications of Exercise Physiology to Patient Management
4. Synergistic interaction between exercise and insulin on peripheral glucose uptake.
5. Barriers to Physical Activity Among Patients With Type 1 Diabetes
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. No insulin degludec dose adjustment required after aerobic exercise for people with type 1 diabetes: the ADREM study;Diabetologia;2023-03-07
2. Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL Around Spontaneous Exercise Sessions in Adults with Type 1 Diabetes: A Randomized Cross-Over Trial (ULTRAFLEXI-1 Study);Diabetes Technology & Therapeutics;2023-03-01
3. Association of HbA1c with VO2max in Individuals with Type 1 Diabetes: A Systematic Review and Meta-Analysis;Metabolites;2022-10-24
4. A Brief Review on the Evolution of Technology in Exercise and Sport in Type 1 Diabetes: Past, Present, and Future;Diabetes Technology & Therapeutics;2021-11-30
5. Comparative Efficacy and Safety of Ultra-Long-Acting, Long-Acting, Intermediate-Acting, and Biosimilar Insulins for Type 1 Diabetes Mellitus: a Systematic Review and Network Meta-Analysis;Journal of General Internal Medicine;2021-03-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3